Being Freed by Who I Am
Every few days, I go out to our Little Free Library and change the messages on the two side walls, which are covered in ... Read more
-
-
It Was a Lazy Sunday Afternoon — Not!
It all started on the hottest day of the year here in the U.K. My phone said it was 99 F. An old friend ... Read more -
‘Crip Camp’: Disability Looking Me Right in the Eye
In early July, I wrote a column about Disability Pride Month. It’s not for me, I said. I questioned the word “pride” and asked ... Read more -
New Patent Filing for QuadraMune Relates to Potential in Aiding Memory
Therapeutics Solutions International has announced filing a new patent covering the memory protective effects of its natural nutritional supplement QuadraMune, as seen in an animal model of ... Read more -
Ofatumumab Seen as Superior to Aubagio at Lowering Relapse Rates in Phase 3 Trials
Novartis‘ ofatumumab outperformed Aubagio (teriflunomide) at lowering the frequency of relapses and preventing disability progression among people with relapsing forms of multiple sclerosis ... Read more
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more